Login to Your Account

NewCo News

Andarix Takes on Late-Stage Lung Cancer, Gets Personal

By Catherine Shaffer
BioWorld Today Contributing Writer

Thursday, December 15, 2011

More people die of lung cancer than any other cancer. In 2010, 162,460 deaths were attributed to non-small-cell lung cancer (NSCLC), and 174,470 new diagnoses were made. Surgery is the first line of defense against lung cancer, but late-stage cancer is not resectable, and chemotherapy only increases survival by four months to five months.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription